- Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
-
Kang JH, Park DJ, Lee JW, Lee KE, Wen L, Kim TJ, Park YW, Lee SS
- KMID: 1794597
- J Korean Med Sci.
- 2014 Sep;29(9):1205-1211.
- doi: 10.3346/jkms.2014.29.9.1205
We investigated the compliance of Korean patients using tumor necrosis factor (TNF) inhibitors to treat rheumatoid arthritis (RA) and ankylosing spondylitis (AS), and identified potential predictors associated with treatment discontinuation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
-
Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH
- KMID: 1796912
- J Korean Med Sci.
- 2014 Jan;29(1):38-42.
- doi: 10.3346/jkms.2014.29.1.38
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of... -
- CITED
-
- Close
- SHARE
-
- Close
